TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer” May 1, 1992
TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test August 5, 1977
